Prebiotics, Probiotics, Synbiotics and Functional Foods in Control and Treatment of Type II Diabetes Mellitus and Colorectal Cancer
Research Output:
Chapter in Book/Report/Conference proceeding
Chapter (peer-reviewed)
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Publication metrics
PlumX, opens in new tab
Captures
18
Abstract
Prebiotics, probiotics and synbiotics are components that enhance human health by several mechanisms. Patients suffering from type II diabetes mellitus (T2DM) and colorectal cancer have seen benefits when treated with a prebiotic, probiotic or synbiotic therapy. These benefits include the improvement of their lipid profile, oxidative stress status, as well as the modulation of the inflammatory and immune responses. The associated benefits of prebiotic, probiotic or synbiotic functional foods have been studied, showing promising results into the prevention or control of diabetes and colorectal cancer. This novelty research provides new evidence that the use of functional foods along with medical therapy could be used to further enhance patient’s health.
Publication Information
Output type
Research Output:
Chapter in Book/Report/Conference proceeding
Chapter (peer-reviewed)
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 345-362Publication milestones
- Published - 27/10/2015
Publication status
Published - 27/10/2015
Publication series
- Publication series name: Probiotics and Prebiotics in Human Nutrition and Health
